Actively Recruiting
Establishment of a Registry of Patients With Parathyroid Disease
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-29
1200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are establishing a registry to include all patients diagnosed with parathyroid diseases such as hyperparathyroidism or hypoparathyroidism who have been evaluated at the Endocrinology Operating Unit. The goal is to collect and study biochemical, clinical, radiological, medico-nuclear, and histological data over a long period to better understand these conditions. This observational study spans 30 years, enrolling patients seen from January 1, 2000, to December 31, 2029. The registry will track patients through at least two endocrinology visits to confirm diagnosis and consent. Data collection includes biochemical tests, clinical symptom monitoring, imaging studies, and histopathological evaluations. Follow-up for each patient is expected to last about 10 years, with continuous updates until the registry closes at the end of 2039. Participants will be observed over time with regular assessments of biochemical markers, clinical symptoms, imaging results, and tissue characteristics related to parathyroid disorders. The research team will monitor these outcomes longitudinally to observe disease progression and related health effects. This study involves no treatment interventions, focusing on collecting comprehensive data to support future research efforts.
CONDITIONS
Brief Title
Establishment of a Registry of Patients With Parathyroid Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters including calcemia, parathormone, phosphormia, creatinine, albumin, and vitamin D25OH
- Providing informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
At least 2 endocrinology visits for diagnosis and evaluation
Duration - Up to 10 years
Participants who undergo routine care are observed with ongoing biochemical, clinical, radiological, and histopathological assessments related to parathyroid pathology.
Regular visits as part of routine endocrine care over 10 years
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
U
Uberto Pagotto, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here